Key facts
- EmpNia’s last known valuation is $44.0M (Mar 2026).
- It has raised $12.2M across 2 recorded rounds; the latest was Early Stage VC ($9.1M) in Nov 2025.
- Notable investors include Texas Medical Center, Seraph Group.
- EmpNia has filed 4 Form Ds with the SEC since 2023, most recently Mar 2026 ($9.1M sold to 90 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for EmpNia
Funding rounds
2 roundsAbout EmpNia
Developer of a precision image-guided radiation therapy system designed for the treatment of cancer patients. The company provides accurate, universal, easy-to-use, and cost-effective respiratory motion management systems, and they offer a wearable fiber optic sensing product, enabling medical staff to deliver precise treatment.
- Sector
- Healthcare
- HQ
- Eden Prairie, MN, United States
- Founded
- 2020
- Employees
- 4
- Website
- empnia.com/
- Ownership
- Privately Held (backing)
EmpNia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EmpNia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EmpNia in its N-PORT filings yet. We sweep new filings monthly.